Arcturus Q1 net loss widens to $27M; appoints Dennis Mulroy as CFO

Arcturus Therapeutics Holdings Inc.

2026-Q1 EPS reported -$0.95 revenue$2,061,000

Net loss of $27.0M ($0.95/diluted share), compared to $14.1M loss ($0.52/share) in Q1 2025.
Total operating expenses fell to $31.0M from $46.2M; revenue down $27.3M due to pivot from infectious disease.
Cash and equivalents $213.4M, runway beyond Q2 2028. Cash decreased $19.4M from Dec 2025.
ARCT-032 CF Phase 2 study enrollment initiated; ARCT-810 OTC deficiency gets FDA clarity for pivotal pediatric path.
Dennis Mulroy appointed CFO effective May 1, 2026; base salary $520k, options for 100k shares.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dennis Mulroy

Chief Financial Officer

ARCT · Arcturus Therapeutics Holdings Inc.

Effective: 2026-05-01
Filed: May 7, 2026, 7:59 PM ET

Effective May 1, 2026, Dennis Mulroy, 71, was appointed Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Arcturus Therapeutics Holdings Inc. reported financial results for the quarter ended March 31, 2026.

Period: the quarter ended March 31, 2026
Result: reported results

Exact text from the filing

today announced its financial results for the quarter ended March 31, 2026, and provided corporate updates.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dennis Mulroy was appointed as Chief Financial Officer at Arcturus Therapeutics Holdings Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Effective May 1, 2026, Dennis Mulroy, 71, was appointed Chief Financial Officer of the Company.

View on SEC.gov

580 earnings releases filed in the last 30 days. Browse all earnings releases →

Arcturus Therapeutics Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001193805-26-000573

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.